What is a risk-sharing agreement?
Risk-sharing agreements link payment for a product to its real-world performance. If the therapy does not meet predefined clinical or economic outcomes, the company may provide discounts, rebates, or other concessions. Agreements can be financial, outcome-based, or a combination of both.
Why are risk-sharing agreements important in Market Access?
They align stakeholder incentives and support access to high-cost or innovative treatments. These agreements demonstrate confidence in a product’s value and can facilitate reimbursement when uncertainty about effectiveness or budget impact exists. They also promote the use of real-world data in ongoing evaluation.
